Jia-Rou Liu

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Atrial Fibrillation

Acute Myocardial Infarction

Coronary Artery Bypass Grafting

Top Venues

International journal of rheumatic diseases

Journal of clinical medicine

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ping-Han Tsai, Chang Fu Kuo, Jia-Rou Liu, Pei-Ru Li, Lai-Chu See
Effect of febuxostat on adverse events and mortality in gout in Taiwan: An interrupted time series analysis. International journal of rheumatic diseases 26 (3) (2023)
Ping-Han Tsai, Chang Fu Kuo, Jia-Rou Liu, Pei-Ru Li, Lai-Chu See
Effect of febuxostat on adverse events and mortality in gout in Taiwan: An interrupted time series analysis. International journal of rheumatic diseases 26 (3) (2023)
Ping-Han Tsai, Chang Fu Kuo, Jia-Rou Liu, Pei-Ru Li, Lai-Chu See
Effect of febuxostat on adverse events and mortality in gout in Taiwan: An interrupted time series analysis. International journal of rheumatic diseases (2023)
Min-Hao Lin, Huang-Yu Yang, Chieh-Li Yen, Chao-Yi Wu, Chang-Chyi Jenq, George Kuo, Wei-Sheng Peng, Jia-Rou Liu, Ya-Chung Tian, Chih-Wei Yang, Gerard F Anderson, Lai-Chu See
Pioglitazone Is Associated with Lower Major Adverse Cardiovascular and Cerebrovascular Events than DPP4-Inhibitors in Diabetic Patients with End-Stage Renal Disease: A Taiwan Nationwide Cohort Study, 2006-2016. Journal of clinical medicine 9 (11) (2020)
Chi-Jen Chang, Ying-Chang Tung, Jia-Rou Liu, Shu-Hao Chang, Chi-Tai Kuo, Lai-Chu See
Efficacy and Safety of Ticagrelor vs. Clopidogrel in East Asian Patients with Acute Myocardial Infarction: A Nationwide Cohort Study. Clinical pharmacology and therapeutics 109 (2) (2020)